Publication | Open Access

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

AsthmaInflammatory Lung DiseaseLung InflammationImmunologyClinical TrialsPulmonary MedicinePharmacotherapyEosinophilic DisorderEosinophilic ExacerbationsMedicinePulmonary Disease